The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620856
Title:
The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project.
Authors:
Teare, H. J. A.; de Masi, F.; Banasik, K.; Barnett, A.; Herrgard, S.; Jablonka, B.; Postma, J. W. M.; McDonald, Timothy J. ( 0000-0003-3559-6660 ) ; Forgie, I.; Chmura, P. J.; Rydzka, E. K.; Gupta, R.; Brunak, S.; Pearson, E.; Kaye, J.
Abstract:
Biomedical research projects involving multiple partners from public and private sectors require coherent internal governance mechanisms to engender good working relationships. The DIRECT project is an example of such a venture, funded by the Innovative Medicines Initiative Joint Undertaking (IMI JU). This paper describes the data access policy that was developed within DIRECT to support data access and sharing, via the establishment of a 3-tiered Data Access Committee. The process was intended to allow quick access to data, whilst enabling strong oversight of how data were being accessed and by whom, and any subsequent analyses, to contribute to the overall objectives of the consortium.
Citation:
The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project. 2018, 14 (1):20 Life Sci Soc Policy
Publisher:
Springer
Journal:
Life sciences, society and policy
Issue Date:
4-Sep-2018
URI:
http://hdl.handle.net/11287/620856
DOI:
10.1186/s40504-018-0083-0
PubMed ID:
30182269
Additional Links:
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30182269/
Note:
This article is freely available via Open Access.
Type:
Journal Article
Language:
en
ISSN:
2195-7819
Appears in Collections:
Exeter Clinical Laboratory International (Blood Sciences, Genetics, Cellular Pathology & Microbiology); 2018 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorTeare, H. J. A.en
dc.contributor.authorde Masi, F.en
dc.contributor.authorBanasik, K.en
dc.contributor.authorBarnett, A.en
dc.contributor.authorHerrgard, S.en
dc.contributor.authorJablonka, B.en
dc.contributor.authorPostma, J. W. M.en
dc.contributor.authorMcDonald, Timothy J.en
dc.contributor.authorForgie, I.en
dc.contributor.authorChmura, P. J.en
dc.contributor.authorRydzka, E. K.en
dc.contributor.authorGupta, R.en
dc.contributor.authorBrunak, S.en
dc.contributor.authorPearson, E.en
dc.contributor.authorKaye, J.en
dc.date.accessioned2018-10-04T11:48:10Z-
dc.date.available2018-10-04T11:48:10Z-
dc.date.issued2018-09-04-
dc.identifier.citationThe governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project. 2018, 14 (1):20 Life Sci Soc Policyen
dc.identifier.issn2195-7819-
dc.identifier.pmid30182269-
dc.identifier.doi10.1186/s40504-018-0083-0-
dc.identifier.urihttp://hdl.handle.net/11287/620856-
dc.description.abstractBiomedical research projects involving multiple partners from public and private sectors require coherent internal governance mechanisms to engender good working relationships. The DIRECT project is an example of such a venture, funded by the Innovative Medicines Initiative Joint Undertaking (IMI JU). This paper describes the data access policy that was developed within DIRECT to support data access and sharing, via the establishment of a 3-tiered Data Access Committee. The process was intended to allow quick access to data, whilst enabling strong oversight of how data were being accessed and by whom, and any subsequent analyses, to contribute to the overall objectives of the consortium.en
dc.language.isoenen
dc.publisherSpringeren
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30182269/en
dc.rightsArchived with thanks to Life sciences, society and policy. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.en
dc.subjectWessex Classification Subject Headings::Microbiology. Immunologyen
dc.titleThe governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project.en
dc.typeJournal Articleen
dc.identifier.journalLife sciences, society and policyen
dc.description.noteThis article is freely available via Open Access.en
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.